Clinical trial

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

NCT02306161

Drugs and interventions used in this trial

12 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Cyclophosphamide Normalized identity: cyclophosphamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Doxorubicin Normalized identity: doxorubicinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Doxorubicin Hydrochloride Normalized identity: doxorubicin hydrochlorideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Etoposide Normalized identity: etoposideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Etoposide Phosphate Normalized identity: etoposide phosphateView linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention External Beam Radiation Therapy Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Ganitumab Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Ifosfamide Normalized identity: ifosfamideView linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Stereotactic Radiosurgery Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Therapeutic Surgical Procedure Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vincristine Normalized identity: vincristineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Vincristine Sulfate Normalized identity: vincristine sulfateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2014-12-12

PhasePHASE3

Conditions

Metastatic Ewing Sarcomaunresolved

Metastatic Malignant Neoplasm in the Boneunresolved

Metastatic Malignant Neoplasm in the Bone Marrowunresolved

Metastatic Malignant Neoplasm in the Lungunresolved

Metastatic Peripheral Primitive Neuroectodermal Tumor of Boneunresolved

Peripheral Primitive Neuroectodermal Tumor of Soft Tissuesverified · MONDO: peripheral primitive neuroectodermal tumor of soft tissues

Interventions

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

DoxorubicinDRUG · verified · RxNorm: doxorubicin

Doxorubicin HydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride

EtoposideDRUG · verified · RxNorm: etoposide

Etoposide PhosphateDRUG · verified · RxNorm: etoposide phosphate

External Beam Radiation TherapyRADIATION

GanitumabBIOLOGICAL

IfosfamideDRUG · verified · RxNorm: ifosfamide

Stereotactic RadiosurgeryRADIATION

Therapeutic Surgical ProcedurePROCEDURE

VincristineDRUG · verified · RxNorm: vincristine

Vincristine SulfateDRUG · verified · RxNorm: vincristine sulfate

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

OmahaNebraska, United States7 CincinnatiOhio, United States5 Las VegasNevada, United States5 St LouisMissouri, United States4 The BronxNew York, United States4 LouisvilleKentucky, United States4 TacomaWashington, United States4 New YorkNew York, United States3 ChicagoIllinois, United States3 PhiladelphiaPennsylvania, United States3 BaltimoreMaryland, United States3 San AntonioTexas, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02306161 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.